Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any revenue predictions for this quarter?
Moving with VOLUME!!
Up 12.8% AH to $1.58
I agree with you Dragon Lady. Bit of semantics involved here. The point is that the device is being used on intubated patients at Cedar’s and that there is no surgery required in the traditional sense. It. Is simply placed via the indwelling tube, turned on with a specific protocol and then withdrawn.
While not 1000% sure, I’m nearly certain that the device would be used within the ICU at the bedside and would NOT require placement/usage in a surgical suite.
An excerpt from recent PR:
“The data have been the basis of discussions with the FDA for a near-term path to enable human use for the potential treatment of coronavirus in intubated patients in the intensive care unit (ICU). Beyond the initial pursuit of a coronavirus ICU indication, additional data suggest broader clinical applications for the technology across a range of viral and bacterial pathogens. This includes bacteria implicated in ventilator associated pneumonia (VAP).”
The device would be used at the bedside for ICU patients. Typically, technicians from the company would train the ICU intensivists (MD’s) on the proper usage of the device.
When patients are intubated there are frequent similar actions taken by the staff such as performing suction of secretions, again via the indwelling endotracheal tube. Obviously, I haven’t used this particular device but the concept is quite straightforward.
I’m a physician. You don’t know what you’re talking about. The device is simply threaded through the endotracheal tube which has already been placed such that the patient’s breathing can be assisted by a ventilator. No “surgery” required.
Wow Dragon Lady, you’re so on top of it!!
This thing’s gonna blow soon....
Latest study results provide amazing confirmation of the accuracy of this test!!!!AYTU firing on all cylinders!
$1.73 premarket
Aytu Bioscience, Inc. (AYTU) Upgraded to Strong Buy
https://finance.yahoo.com/news/aytu-bioscience-inc-aytu-upgraded-160004197.html?.tsrc=fin-srch
AYTU upgrade to strong buy, Zack’s rating now #1 rated!
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/aytu-bioscience-inc-aytu-upgraded-160004197.html
Someone’s buying
A few questions for the board.
First a little background:
1)There have been some tests I’ve heard of coming out of China that were not sensitive enough causing false negatives.
2)I understand that in the verification cited for the AYTU test that there were approximately 8% false negatives and zero false positives.
3) The study was done on individuals with symptoms of URI and/or pneumonia and compared to molecular testing for the virus.
My questions are:
1) Since it takes some time for antibodies to form, are these really false negatives? In other words, am I correct in assuming that one would expect a certain percentage of infected patients to test negative since they may not have had enough time to form antibodies.
2) Do we have any information on how the test performs relative to “gold standard” serological tests for Covid-19?
3) Is the test sensitive enough to accurately identify recovered/immune individuals?
I realize that the answers to these questions may not yet exist but in case we have any pharmaceutical experts on the board, thought it was worth reaching out.
GLTA
The sky is falling....the sky is falling!(pathetic)
Misinformation peddlers will be gone soon; they’re just mosquitoes who are about to get zapped....
Breaking out, now
Hedge funds trying to keep us down.... can’t last. Fun knowing this baby’s gonna run sooner or later.
Best cover now, shorts.
Hedge funds are going to have are hard time keeping this baby down. Sorry converting to follow.
Did that a couple of hours ago.
The only practical way to get the nation/world back to work is to do mass antibody testing. We have to identify those who've successfully recovered from the virus and allow them to return to work. The testing will also allow scientists to understand the extent of asymptomatic individuals who may be spreading the disease, to prioritize immune individuals on the front lines of our health care system, and to identify donors for plasma therapy.
Massive worldwide testing will be needed.
https://www.statnews.com/2020/03/27/serological-tests-reveal-immune-coronavirus/
https://www.livescience.com/coronavirus-blood-test-antibodies.html
Got lucky and called the start of our uptrend. Nice find on the Denver Police Dept tweet!
My trader's nose talking. We'll see.
Uptrend starting now IMO.
Bullish flag pattern. Next move up coming by the end of this week.
AYTU rapid finger prick test will be essential tool for returning people to work.; 100’s of millions of them.
This is classic consolidation price action... we’re forming a base for the next legs up.
IMO the demand for this test is so huge that the fact that is produced in China, recent offerings are small factors relative to enormous future revenue potential. Right now it’s all just about execution.
Finger prick test touted again on “The Five”- Fox News
Watching this via Roku app, national feed - Bill Hemmer Reports
Massive demand for point of contact test with rapid results to manage return to work. AYTU will be massive winner....IMHO
Segment was just now on FOX news
Dr Marc Siegel touting rapid pinprick test for antibodies to assess coronavirus. Saying we need this NOW throughout the country.
Sorry, I see now that you meant an additional .40 cents so we’re more or less in agreement.
If the current market cap is around 15 million then wouldn’t 0.75-1.00 seem more likely?
Sorry, tripling in value since February? (Given the market cap of WDDD and increase in value of MRMD stock relative to said market cap)
Basic question: why hasn’t WDDD price reflected MRMD near tripling in value?
You can add me to your list with 1.5 million shares long.